Breaking News

Sepiprod Gains EXCiPACT Certification

Becomes first site in France to be EXCiPACT-registered

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sepiprod, a production site of Seppic based in Castres, France, has received EXCiPACT certification from MDC Medical Device Certification GmbH, one of EXCiPACT’s internationally-recognized Certification Bodies. Seppic is a subsidiary of Air Luquide.   The site underwent a rigorous assessment process by EXCiPACT auditors to evaluate GMP/GDP compliance for excipients. Sepiprod is the first site in France to be EXCiPACT-registered. Other certified sites include Aug. Hedinder, BASF, and Merck KGaA i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters